Daiichi's Lixiana nabs backing from NICE; Recipharm gets financing; GSK, Novartis India plans win watchdog approval;

@FiercePharma: Did squirrels pass a killer virus to people? FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: Which companies had highest comped CEOs? Hint, most are U.S. and did not necessarily make the most money. Special report | Follow @EricPFierce

@CarlyHFierce: I triple-dog-dare someone to make this new creepy-as-hell $GSK vaccine ad their Twitter pic. Story | Follow @CarlyHFierce

> The cost-effectiveness watchdogs at the National Institute for Health and Care Excellence (NICE) backed Daiichi Sankyo's new warfarin-alternative anticoagulant Lixiana to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE). Release

> Recipharm sewed up new bank financing to finance its growth plans from DNB, Handelsbanken and Swedbank. Report

> Indian regulators cleared a variety of pharma's foreign investment proposals for the country, including those from GlaxoSmithKline ($GSK), Novartis ($NVS) and Mylan ($MYL). Report

> The Obama administration issued new rules allowing closely held companies such as Hobby Lobby to opt out of covering contraceptives if they have religious objections. Report

> The Scottish Medicines Consortium blessed the use of Bayer's Nexavar to treat thyroid cancer, a new use for the drug. Report

> India's Dr. Reddy's Laboratories ($RDY) launched its version of Allergan's ($AGN) Alzheimer's pill Namenda in the U.S. Report

Medical Device News

@FierceMedDev: ICYMI: Magic material: graphene protects chemotherapy, but silver-lined catheters break it down. Article | Follow @FierceMedDev

@StacyALawrence: Aum Cardio raises $5M to back hand-held, in-office CAD Dx device. Article | Follow @StacyALawrence

@EmilyWFierce: The experience of having your blood drawn by Theranos, as laid out by @danmunro. More | Follow @EmilyWFierce

> German prosthetics company mulls IPO for 2017. Story

> U.S. House passes provision to keep tabs on medical devices used on patients. Article

Biotech News

@FierceBiotech: Roche hustles to FDA with PhII PD-L1 cancer success for 'breakthrough' star atezolizumab. News | Follow @FierceBiotech

@JohnCFierce: You want to see why execs are leaving Big Pharma for biotech? It's where the money is. Report | Follow @JohnCFierce

@DamianFierce: Actual line: "Sorrento recently entered into a definitive agreement with NantPharma to acquire the rights for Cynviloq™ from Sorrento." | Follow @DamianFierce

> As schizophrenia rivals rush in, Otsuka and Lundbeck gain FDA OK for Rexulti. News

> Anacor soars as its eczema cream succeeds in Phase III. Article

Animal Health News

> FDA cracks down on Vegas firm selling unapproved kidney drug for dogs and cats. Article

> Perdue ditches all antibiotics for new chicken line, General Mills goes cage-free. Report

> Did squirrels pass a killer virus to people? More

> Senate committee, USDA, poultry producers meet to discuss deadly U.S. avian flu outbreak. Story

> Sweden's Oasmia regains rights to cancer drugs from Zoetis, files for $23M IPO. Article

Biotech IT News

> 21st Century Cures Act clears House with data sharing, standardization sections intact. Story

> Genomics vs YouTube: Which will have the greater computing requirements in 2025? More

> GSK working to build Apple's ResearchKit into its clinical trials. Report

> Financially motivated hackers break into 3 major pharma companies in 18 months. Article

> Core Informatics snags $17.5M to fuel lab software land grab. Story

Pharma Marketing News

> Novartis off to scorching start with Copaxone generic Glatopa. Article

> Novo Nordisk looks past blockbuster Victoza with PhIII success for weekly GLP-1 med. Item

> For Entresto rollout, Novartis marketing mixes tried-and-true with new-and-different. Story

> How does the Keytruda-Opdivo marketing battle stack up? More

> GSK's big, bad whooping cough vaccination campaign bares its teeth. Article

And Finally... Walgreen's ($WBA) tapped interim CEO Stefano Pessina to stick around in the top job. Report

Suggested Articles

The CD19 antibody, used in tandem with Celgene's Revlimid, represents the first FDA approval in second-line diffuse large B-cell lymphoma.

Sanofi has faced a probe into birth defects tied to seizure med Depakine for years. Now, the investigation is moving forward on manslaughter charges.

Pfizer launched a multichannel awareness campaign centered on a first-ever radio station dedicated solely to metastatic breast cancer.